Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Brugia malayi | hypothetical protein | 0.0027 | 0.0033 | 0.0033 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0073 | 0.253 | 0.2505 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0115 | 0.0082 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0182 | 0.851 | 0.8471 |
Onchocerca volvulus | 0.0085 | 0.3196 | 0.3562 | |
Trypanosoma brucei | hexokinase | 0.0085 | 0.3196 | 0.3173 |
Echinococcus granulosus | hexokinase type 2 | 0.0085 | 0.3196 | 0.3017 |
Loa Loa (eye worm) | Sodium:neurotransmitter symporter family protein | 0.0031 | 0.0256 | 0.0256 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0073 | 0.253 | 0.2505 |
Brugia malayi | hexokinase type II | 0.0027 | 0.0039 | 0.0039 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0073 | 0.253 | 0.2505 |
Entamoeba histolytica | hexokinase 1 | 0.0085 | 0.3196 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0073 | 0.253 | 0.2505 |
Onchocerca volvulus | Hexokinase homolog | 0.0053 | 0.1471 | 0.1473 |
Trypanosoma brucei | unspecified product | 0.0041 | 0.0811 | 0.0781 |
Echinococcus multilocularis | dna polymerase kappa | 0.0041 | 0.0811 | 0.0569 |
Echinococcus granulosus | geminin | 0.0181 | 0.8413 | 0.8371 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0073 | 0.253 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Loa Loa (eye worm) | glutathione reductase | 0.021 | 1 | 1 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0031 | 0.0256 | 0.0256 |
Echinococcus multilocularis | hexokinase | 0.0085 | 0.3196 | 0.3017 |
Leishmania major | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0073 | 0.253 | 0.2505 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 0.851 | 0.851 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0073 | 0.253 | 0.2334 |
Echinococcus granulosus | hexokinase | 0.0085 | 0.3196 | 0.3017 |
Plasmodium falciparum | thioredoxin reductase | 0.0073 | 0.253 | 0.2505 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0256 | 0.0256 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0073 | 0.253 | 0.2505 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0041 | 0.0811 | 0.0569 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0256 | 0.0256 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0073 | 0.253 | 0.2505 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0073 | 0.253 | 0.2505 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.021 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.1464 | 0.1464 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0256 | 0.0256 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0115 | 0.0082 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0041 | 0.0811 | 0.0569 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0073 | 0.253 | 0.2505 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0073 | 0.253 | 0.1871 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.021 | 1 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.021 | 1 | 1 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0073 | 0.253 | 0.253 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0068 | 0.229 | 0.2265 |
Leishmania major | hexokinase, putative | 0.0085 | 0.3196 | 0.3173 |
Echinococcus multilocularis | hexokinase | 0.0085 | 0.3196 | 0.3017 |
Toxoplasma gondii | thioredoxin reductase | 0.021 | 1 | 1 |
Loa Loa (eye worm) | hexokinase | 0.0085 | 0.3196 | 0.3196 |
Loa Loa (eye worm) | Sodium:neurotransmitter symporter family protein | 0.0031 | 0.0256 | 0.0256 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0073 | 0.253 | 0.1871 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.0031 | 0.0256 | 0.0224 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0182 | 0.851 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0073 | 0.253 | 0.1871 |
Leishmania major | hexokinase, putative | 0.0085 | 0.3196 | 0.3173 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0073 | 0.253 | 1 |
Trypanosoma brucei | unspecified product | 0.0028 | 0.0115 | 0.0082 |
Brugia malayi | Sodium:neurotransmitter symporter family protein 1, putative | 0.0031 | 0.0256 | 0.0256 |
Trypanosoma brucei | hexokinase, putative | 0.0085 | 0.3196 | 0.3173 |
Loa Loa (eye worm) | hexokinase | 0.0053 | 0.1471 | 0.1471 |
Plasmodium falciparum | glutathione reductase | 0.0073 | 0.253 | 0.2505 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0073 | 0.253 | 0.2505 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Loa Loa (eye worm) | serotonin transporter b | 0.0182 | 0.851 | 0.851 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.021 | 1 | 1 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0041 | 0.0811 | 0.0811 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0073 | 0.253 | 1 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.0031 | 0.0256 | 0.0224 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Plasmodium vivax | thioredoxin reductase, putative | 0.021 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0073 | 0.253 | 0.2505 |
Brugia malayi | Thioredoxin reductase | 0.021 | 1 | 1 |
Echinococcus multilocularis | dna polymerase eta | 0.0068 | 0.229 | 0.2088 |
Leishmania major | DNA polymerase eta, putative | 0.004 | 0.0744 | 0.0714 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0073 | 0.253 | 0.2505 |
Trypanosoma cruzi | hexokinase, putative | 0.0085 | 0.3196 | 0.3173 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0031 | 0.0256 | 0.0256 |
Loa Loa (eye worm) | thioredoxin reductase | 0.021 | 1 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0073 | 0.253 | 1 |
Leishmania major | trypanothione reductase | 0.021 | 1 | 1 |
Schistosoma mansoni | DNA polymerase eta | 0.0068 | 0.229 | 0.2088 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0073 | 0.253 | 0.2505 |
Echinococcus multilocularis | hexokinase type 2 | 0.0085 | 0.3196 | 0.3017 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.0811 | 0.0781 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0073 | 0.253 | 0.2334 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0039 | 0.0039 |
Leishmania major | DNA polymerase eta, putative | 0.0068 | 0.229 | 0.2265 |
Trypanosoma brucei | unspecified product | 0.0028 | 0.0115 | 0.0082 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0041 | 0.0811 | 0.0569 |
Brugia malayi | Hexokinase family protein | 0.0085 | 0.3196 | 0.3196 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0073 | 0.253 | 0.2334 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0073 | 0.253 | 0.2505 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0068 | 0.229 | 0.229 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0073 | 0.253 | 1 |
Brugia malayi | hypothetical protein | 0.0031 | 0.0256 | 0.0256 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.0811 | 0.0781 |
Echinococcus granulosus | dna polymerase eta | 0.0068 | 0.229 | 0.2088 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0073 | 0.253 | 0.5 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0073 | 0.253 | 0.2505 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0073 | 0.253 | 0.2505 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0073 | 0.253 | 0.2505 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0068 | 0.229 | 0.2265 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0073 | 0.253 | 1 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.004 | 0.0744 | 0.0714 |
Plasmodium vivax | amine transporter, putative | 0.0031 | 0.0256 | 0.0224 |
Onchocerca volvulus | 0.0182 | 0.851 | 1 | |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0182 | 0.851 | 0.851 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.004 | 0.0744 | 0.0714 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0548 | 0.0548 |
Echinococcus granulosus | hexokinase | 0.0085 | 0.3196 | 0.3017 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0039 | 0.0039 |
Onchocerca volvulus | 0.0053 | 0.1471 | 0.1473 | |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0041 | 0.0811 | 0.0569 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.229 | 0.229 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.0031 | 0.0256 | 0.0224 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0182 | 0.851 | 0.851 |
Schistosoma mansoni | hypothetical protein | 0.0181 | 0.8413 | 0.8371 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0041 | 0.0811 | 0.0811 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.021 | 1 | 1 |
Entamoeba histolytica | hexokinase 2 | 0.0085 | 0.3196 | 1 |
Trypanosoma brucei | hexokinase | 0.0085 | 0.3196 | 0.3173 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.1464 | 0.1464 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0073 | 0.253 | 0.1871 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0073 | 0.253 | 0.2505 |
Brugia malayi | hexokinase | 0.0085 | 0.3196 | 0.3196 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0031 | 0.0256 | 0.0256 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0073 | 0.253 | 0.2505 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0053 | 0.1478 | 0.1478 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.0811 | 0.0781 |
Plasmodium vivax | glutathione reductase, putative | 0.021 | 1 | 1 |
Plasmodium falciparum | transporter, putative | 0.0031 | 0.0256 | 0.0224 |
Treponema pallidum | hexokinase (hxk) | 0.0085 | 0.3196 | 0.1114 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 0.851 | 0.851 |
Loa Loa (eye worm) | hexokinase | 0.0085 | 0.3196 | 0.3196 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0073 | 0.253 | 0.2505 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.1464 | 0.1464 |
Echinococcus multilocularis | geminin | 0.0181 | 0.8413 | 0.8371 |
Echinococcus multilocularis | serotonin transporter | 0.0182 | 0.851 | 0.8471 |
Brugia malayi | Hexokinase family protein | 0.0053 | 0.1471 | 0.1471 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0073 | 0.253 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.0033 | 0.0033 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.1464 | 0.1464 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.0548 | 0.0548 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0182 | 0.851 | 0.851 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0256 | 0.0256 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0073 | 0.253 | 0.2505 |
Echinococcus granulosus | hexokinase | 0.0085 | 0.3196 | 0.3017 |
Onchocerca volvulus | 0.0085 | 0.3196 | 0.3562 | |
Plasmodium falciparum | hexokinase | 0.0085 | 0.3196 | 0.3173 |
Toxoplasma gondii | hypothetical protein | 0.0031 | 0.0256 | 0.0224 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0256 | 0.0256 |
Schistosoma mansoni | hexokinase | 0.0085 | 0.3196 | 0.3017 |
Echinococcus granulosus | dna polymerase kappa | 0.0041 | 0.0811 | 0.0569 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0073 | 0.253 | 0.5 |
Echinococcus multilocularis | hexokinase | 0.0085 | 0.3196 | 0.3017 |
Loa Loa (eye worm) | hexokinase type II | 0.0085 | 0.3196 | 0.3196 |
Plasmodium falciparum | amino acid transporter, putative | 0.0031 | 0.0256 | 0.0224 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0053 | 0.1478 | 0.1478 |
Trypanosoma cruzi | hexokinase, putative | 0.0085 | 0.3196 | 0.3173 |
Plasmodium vivax | hexokinase, putative | 0.0085 | 0.3196 | 0.3173 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0073 | 0.253 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0031 | 0.0256 | 0.0224 |
Echinococcus granulosus | serotonin transporter | 0.0182 | 0.851 | 0.8471 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0041 | 0.0811 | 0.0781 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0256 | 0.0256 |
Plasmodium falciparum | thioredoxin reductase | 0.021 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.0256 | 0.0256 |
Toxoplasma gondii | hexokinase | 0.0085 | 0.3196 | 0.3173 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0073 | 0.253 | 0.2505 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.0548 | 0.03 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0028 | 0.0115 | 0.0082 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0182 | 0.851 | 0.8471 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0041 | 0.0811 | 0.0781 |
Loa Loa (eye worm) | hypothetical protein | 0.0182 | 0.851 | 0.851 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0073 | 0.253 | 0.2505 |
Toxoplasma gondii | hypothetical protein | 0.0031 | 0.0256 | 0.0224 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.1724 | 0.1724 |
Plasmodium falciparum | glutathione reductase | 0.021 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0181 | 0.8413 | 0.8371 |
Onchocerca volvulus | 0.0085 | 0.3196 | 0.3562 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 63.9 uM | Ability to inhibit [3H]-paroxetine binding to cloned human serototnin (5-HT) transporter; Average of two experiments | ChEMBL. | 15177457 |
Ki (binding) | = 63.9 uM | Ability to inhibit [3H]-paroxetine binding to cloned human serototnin (5-HT) transporter; Average of two experiments | ChEMBL. | 15177457 |
Ki (binding) | = 97.1 uM | Ability to inhibit [3H]-nisoxatine binding to cloned human norepinephrine (NE) transporter; Average of two experiments | ChEMBL. | 15177457 |
Ki (binding) | = 97.1 uM | Ability to inhibit [3H]-nisoxatine binding to cloned human norepinephrine (NE) transporter; Average of two experiments | ChEMBL. | 15177457 |
Ki (binding) | = 130 uM | Ability to inhibit [3H]-mazindol binding to cloned human dopamine (DA) transporter; Average of two experiments | ChEMBL. | 15177457 |
Ki (binding) | = 130 uM | Ability to inhibit [3H]-mazindol binding to cloned human dopamine (DA) transporter; Average of two experiments | ChEMBL. | 15177457 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.